Sanguine Media Limited has adjourned its board meeting to June 9, 2026, to conclude the approval of the audited financial results for the quarter and financial year ended March 31, 2026. The board initially convened on May 29, 2026, and reconvened on May 30, 2026, but could not complete the agenda due to pending discussions on the financial statements. The final meeting is scheduled to take place at the company's registered office in Chennai.

The board deliberated extensively on the audited financial results and other related financial statements during the sessions on May 29 and May 30. The discussions on May 29 continued until 8:30 P.M., and the meeting resumed on May 30 at 11:00 A.M., lasting until 6:35 P.M. The adjournment was necessitated by the requirement for further consideration of the financial statements and related matters.

Key Meeting Details

The outcome of the adjourned board meeting will be submitted to the stock exchange immediately upon conclusion. The approval of the financial results will provide insights into the company's performance for the final quarter of FY26 and the annual financial outcome. The intimation was submitted to BSE Limited under Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Sanguine Media Limited has informed BSE Limited about the successful completion of its independent directors meeting held on March 20, 2026, as mandated under Regulation 25(3) of the SEBI (LODR) Regulations, 2015 and Schedule IV of the Companies Act, 2013.

Meeting Details and Regulatory Compliance

The meeting was conducted at the company's registered office for the Financial Year 2025-26, demonstrating the company's commitment to corporate governance standards. The session was presided over by the independent directors present and lasted for 30 minutes.

Key Agenda Items Reviewed

The independent directors conducted a comprehensive evaluation covering multiple aspects of corporate governance:

• Board Performance Review: Assessed the performance of non-independent directors and evaluated the board of directors as a collective entity
• Chairperson Evaluation: Reviewed the performance of the company's chairperson, incorporating feedback from both executive and non-executive directors
• Information Flow Assessment: Evaluated the quality, quantity, and timeliness of information exchange between management and the board to ensure directors can perform their duties effectively

Corporate Communication

The outcome was communicated to BSE Limited through a formal letter signed by Aditya R Suryavanshi, Director (DIN: 07703306), ensuring transparency and regulatory compliance. The company maintains its registered office at Plot No 135A, 1st Floor, Chandran Nagar Main Road Chromepet, Chennai - 600044, Tamil Nadu.

This annual independent directors meeting represents a crucial component of Sanguine Media Limited's corporate governance framework, ensuring independent oversight and evaluation of the company's leadership and operational processes.